KLK3 and posterior cortical atrophy: The main biomarker currently used for diagnosis of PCa is prostate-specific antigen (PSA) which harbors good diagnostic values, however cannot distinguish PCa from resembling milder prostate disorders like benign prostate hyperplasia (BPH) and prostatitis (5).